|
MAT2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.35630000008824E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05210000000966E-06 |
| Normal-vs-Stage2 |
2.302000E-02 |
| Normal-vs-Stage3 |
1.008570E-01 |
| Normal-vs-Stage4 |
6.376100E-02 |
| Stage1-vs-Stage2 |
8.290000E-01 |
| Stage1-vs-Stage3 |
4.405400E-01 |
| Stage1-vs-Stage4 |
9.466800E-01 |
| Stage2-vs-Stage3 |
7.164000E-01 |
| Stage2-vs-Stage4 |
9.291400E-01 |
| Stage3-vs-Stage4 |
7.190200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.71860000026159E-07 |
| Normal-vs-AfricanAmerican |
3.13969999998776E-06 |
| Normal-vs-Asian |
4.829800E-01 |
| Caucasian-vs-AfricanAmerican |
6.707200E-01 |
| Caucasian-vs-Asian |
6.629600E-01 |
| AfricanAmerican-vs-Asian |
4.771000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.49929999923881E-08 |
| Normal-vs-Female |
4.780400E-03 |
| Male-vs-Female |
2.960600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.080500E-03 |
| Normal-vs-Extreme_Weight |
2.28829999999736E-05 |
| Normal-vs-Obese |
5.630900E-04 |
| Normal-vs-Extreme_Obese |
3.482200E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.389400E-01 |
| Normal_Weight-vs-Obese |
5.966000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.279200E-01 |
| Extreme_Weight-vs-Obese |
5.760200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.517000E-01 |
| Obese-vs-Extreme_Obese |
4.412200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.663800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.381700E-03 |
| Normal-vs-Age(61-80Yrs) |
7.26110005455638E-09 |
| Normal-vs-Age(81-100Yrs) |
2.689900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.251000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.532200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.113600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.134000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.660800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.550600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.31030000031174E-07 |
| Normal-VS-Type2 PRCC |
5.741100E-03 |
| Normal-VS-KIRP CIMP |
3.33509997396675E-09 |
| Normal-VS-Unclassified PRCC |
1.454040E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.922400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.978200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.544000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.963300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.712400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.762000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.204900E-03 |
| Normal-vs-N1 |
5.142200E-03 |
| Normal-vs-N2 |
4.04160000000431E-06 |
| N0-vs-N1 |
8.261000E-01 |
| N0-vs-N2 |
3.012000E-01 |
| N1-vs-N2 |
1.246350E-01 |
|
|
